Approach Cross-functional pipeline governance teams meet to develop an innovative product portfolio that drives positive global health outcomes to: Address unmet medical needs and barriers to patient experience Increase the speed and breadth of patient access Drive excellence in product life cycle management Understand long-term impacts of scientific�advances In trials represent the diversity of the communities with the relevant disease.